t-Butyl ester PEG reagent, tert-Butyl 2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetate, Purity 95%

Cat. No.: X24-10-WXX462

t-Butyl ester PEG reagent, tert-Butyl 2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetate, Purity 95%

Synonym: 1950635-36-5; tert-butyl 2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetate; Thalidomide-4-O-CH2-COO(t-Bu); ACETIC ACID, 2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]OXY]-, 1,1-DIMETHYLETHYL ESTER; SCHEMBL17839798

  • CAS Number: 1950635-36-5
  • PubChem CID: 121411060
Size
250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
tert-Butyl 2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetate is a reagent grade PROTAC linker featuring a thalidomide analog, a hydrophilic PEG spacer, and a t-butyl ester.
Molecular Weight
388.4
Molecular Formula
C19H20N2O7
Functional Group 1
t-Butyl ester
Functional Group 2
None
Functional Group 3
None
Reactive Group 1
Acid
Form
Solid
Purity
95%
Identity
Confirmed by NMR.
Applications
tert-Butyl 2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetate is utilized in synthesizing targeted drug conjugates, and bioconjugation research. Thalidomide recruits E3 Ligase for the ubiquitination and subsequent destruction of a given protein.
Storage
Store at -20°C.
For Research Use Only. Not For Clinical Use.

Unleash the full potential of glycochemistry research with CD BioGlyco, the top CRO company committed to advancing the understanding of glycobiology through tailored solutions and exceptional expertise.

Copyright © CD BioGlyco. All Rights Reserved.
Top